Curaleaf Holdings (CURLF) Change in Acquisitions & Divestments (2020 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Change in Acquisitions & Divestments of $302000.0 for Q4 2024, up 23.27% on a QoQ basis from $245000.0 in Q3 2024.
Curaleaf Holdings (CURLF) Change in Acquisitions & Divestments (2020 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $302000.0 the latest figure, recorded in Q4 2024.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $302000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $547000.0 (changed N/A YoY) and the FY2025 annual result came in at $749000.0, up 19.27% from the prior year.
- Change in Acquisitions & Divestments improved to $302000.0 in Q4 2024 per CURLF's latest filing, from $245000.0 in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for CURLF reached as high as $9.5 million in Q4 2020 and fell as low as -$451000.0 in Q3 2021.
- A 4-year average of $1.8 million and a median of $1.0 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments sank 77.51% — and 2022, when it jumped 31825.0%.
- Year by year, Change in Acquisitions & Divestments stood at $9.5 million in 2020, then tumbled by 77.51% to $2.1 million in 2021, then plunged by 50.8% to $1.0 million in 2022, then slumped by 71.13% to $302000.0 in 2024.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $302000.0, $245000.0, and $1.0 million for Q4 2024, Q3 2024, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 6.98 Bn | 6.98 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 302,000.00 |
| Dec 31, 2024 | 302,000.00 |
| Sep 30, 2024 | 245,000.00 |
| Sep 30, 2024 | 245,000.00 |
| Jun 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.27 Mn |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 2.13 Mn |
| Dec 31, 2021 | 2.13 Mn |
| Sep 30, 2021 | -451,000.00 |
| Sep 30, 2021 | -451,000.00 |
| Jun 30, 2021 | 2.04 Mn |
| Jun 30, 2021 | 2.04 Mn |
| Mar 31, 2021 | -4,000.00 |
| Mar 31, 2021 | -4,000.00 |
| Dec 31, 2020 | 9.45 Mn |
| Dec 31, 2020 | 9.45 Mn |